{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,30]],"date-time":"2026-08-30T16:30:41Z","timestamp":1788107441127,"version":"build-2803163510"},"reference-count":39,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100004366","name":"Tabriz University of Medical Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004366","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cytokine"],"published-print":{"date-parts":[[2020,3]]},"DOI":"10.1016\/j.cyto.2020.154994","type":"journal-article","created":{"date-parts":[[2020,1,14]],"date-time":"2020-01-14T12:39:27Z","timestamp":1579005567000},"page":"154994","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"special_numbering":"C","title":["Interleukin-17 mRNA expression and serum levels in Beh\u00e7et\u2019s disease"],"prefix":"10.1016","volume":"127","author":[{"given":"Golamreza","family":"Jadideslam","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Houman","family":"Kahroba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khalil","family":"Ansarin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ebrahim","family":"Sakhinia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alireza","family":"Abhar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shahriar","family":"Alipour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jafar","family":"Farhadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sam","family":"Seydi Shirvani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6965-852X","authenticated-orcid":false,"given":"Masoud","family":"Nouri-Vaskeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saeed","family":"Mousavi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1544-4547","authenticated-orcid":false,"given":"Alireza","family":"khabbazi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cyto.2020.154994_b0005","doi-asserted-by":"crossref","first-page":"665","DOI":"10.3389\/fimmu.2019.00665","article-title":"Immunopathogenesis of Beh\u00e7et\u2019s disease","volume":"10","author":"Tong","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.cyto.2020.154994_b0010","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.3389\/fimmu.2019.01067","article-title":"Beh\u00e7et\u2019s disease: an overview of etiopathogenesis","volume":"10","author":"Leccese","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.cyto.2020.154994_b0015","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1016\/j.biopha.2017.04.106","article-title":"Epigenetic alterations in chronic disease focusing on Beh\u00e7et\u2019s disease","volume":"91","author":"Alipour","year":"2017","journal-title":"Rev., Biomed. Pharmacother. = Biomed. Pharmacother."},{"key":"10.1016\/j.cyto.2020.154994_b0020","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.imlet.2018.10.012","article-title":"Determination of mir-155 and mir-146a expression rates and its association with expression level of TNF-alpha and CTLA4 genes in patients with Beh\u00e7et\u2019s disease","volume":"204","author":"Kolahi","year":"2018","journal-title":"Immunol. Lett."},{"issue":"12","key":"10.1016\/j.cyto.2020.154994_b0025","first-page":"1897","article-title":"A single nucleotide polymorphism in the FOXP3 gene associated with Beh\u00e7et\u2019s disease in an Iranian population","volume":"61","author":"Hosseini","year":"2015","journal-title":"Clin. Lab."},{"issue":"4 Suppl 67","key":"10.1016\/j.cyto.2020.154994_b0030","first-page":"S71","article-title":"Th17 cells in Beh\u00e7et\u2019s disease: a new immunoregulatory axis","volume":"29","author":"Hamzaoui","year":"2011","journal-title":"Clin. Exp. Rheumatol."},{"key":"10.1016\/j.cyto.2020.154994_b0035","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.jaut.2018.09.002","article-title":"Efficacy of the anti-IL 17 secukinumab in refractory Beh\u00e7et\u2019s syndrome: a preliminary study","volume":"97","author":"Di Scala","year":"2019","journal-title":"J. Autoimmun."},{"issue":"3","key":"10.1016\/j.cyto.2020.154994_b0040","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1016\/j.jaci.2011.05.029","article-title":"Critical role of IL-21 in modulating TH17 and regulatory T cells in Beh\u00e7et\u2019 disease","volume":"128","author":"Geri","year":"2011","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.cyto.2020.154994_b0045","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1111\/j.1600-065X.2008.00628.x","article-title":"Th17 cells in human disease","volume":"223","author":"Tesmer","year":"2008","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.cyto.2020.154994_b0050","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.imlet.2017.08.008","article-title":"Interleukin-26 is overexpressed in Beh\u00e7et\u2019s disease and enhances Th17 related -cytokines","volume":"190","author":"Kaabachi","year":"2017","journal-title":"Immunol. Lett."},{"key":"10.1016\/j.cyto.2020.154994_b0055","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.imlet.2019.05.004","article-title":"Th 9 cells in Beh\u00e7et\u2019 disease: Possible involvement of IL-9 in pulmonary manifestations","volume":"211","author":"Kaabachi","year":"2019","journal-title":"Immunol. Lett."},{"issue":"5","key":"10.1016\/j.cyto.2020.154994_b0060","doi-asserted-by":"crossref","first-page":"2832","DOI":"10.4049\/jimmunol.164.5.2832","article-title":"High levels of IL-17 in rheumatoid arthritis patients: IL-15 triggers in vitro IL-17 production via cyclosporin A-sensitive mechanism","volume":"164","author":"Ziolkowska","year":"2000","journal-title":"J. Immunol. (Baltimore, Md. 1950)"},{"issue":"1","key":"10.1016\/j.cyto.2020.154994_b0065","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1136\/gut.52.1.65","article-title":"Increased expression of interleukin 17 in inflammatory bowel disease","volume":"52","author":"Fujino","year":"2003","journal-title":"Gut"},{"issue":"11","key":"10.1016\/j.cyto.2020.154994_b0070","doi-asserted-by":"crossref","first-page":"2455","DOI":"10.1002\/1529-0131(200011)43:11<2455::AID-ANR12>3.0.CO;2-K","article-title":"Increased interleukin-17 production in patients with systemic sclerosis","volume":"43","author":"Kurasawa","year":"2000","journal-title":"Arthritis Rheum."},{"issue":"4","key":"10.1016\/j.cyto.2020.154994_b0075","doi-asserted-by":"crossref","first-page":"575","DOI":"10.15171\/apb.2018.066","article-title":"A review of herbal therapy in multiple sclerosis","volume":"8","author":"Mojaverrostami","year":"2018","journal-title":"Adv. Pharm. Bull."},{"issue":"1","key":"10.1016\/j.cyto.2020.154994_b0080","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.cyto.2014.11.020","article-title":"Involvement of the IL-23\/IL-17 axis and the Th17\/Treg balance in the pathogenesis and control of autoimmune arthritis","volume":"74","author":"Astry","year":"2015","journal-title":"Cytokine"},{"issue":"26","key":"10.1016\/j.cyto.2020.154994_b0085","doi-asserted-by":"crossref","first-page":"2534","DOI":"10.1056\/NEJMoa1505066","article-title":"Secukinumab, an interleukin-17A inhibitor, ankylosing spondylitis","volume":"373","author":"Baeten","year":"2015","journal-title":"N. Engl. J. Med."},{"issue":"9999","key":"10.1016\/j.cyto.2020.154994_b0090","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1016\/S0140-6736(15)61134-5","article-title":"Secukinumab, a human anti-interleukin-17A monoclonal antibody, in patients with psoriatic arthritis (FUTURE 2): a randomised, double-blind, placebo-controlled, phase 3 trial","volume":"386","author":"McInnes","year":"2015","journal-title":"Lancet (London, England)"},{"issue":"6","key":"10.1016\/j.cyto.2020.154994_b0095","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1038\/nm1585","article-title":"TH17 cells contribute to uveitis and scleritis and are expanded by IL-2 and inhibited by IL-27\/STAT1","volume":"13","author":"Amadi-Obi","year":"2007","journal-title":"Nat. Med."},{"issue":"5","key":"10.1016\/j.cyto.2020.154994_b0100","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1016\/j.jaci.2007.01.010","article-title":"IL-23 promotes CD4+ T cells to produce IL-17 in Vogt-Koyanagi-Harada disease","volume":"119","author":"Chi","year":"2007","journal-title":"J. Allergy Clin. Immunol."},{"issue":"1","key":"10.1016\/j.cyto.2020.154994_b0105","doi-asserted-by":"crossref","first-page":"48","DOI":"10.3109\/03009742.2012.704391","article-title":"Elevated levels of interleukin-27 and effect on production of interferon-gamma and interleukin-17 in patients with Beh\u00e7et\u2019s disease","volume":"42","author":"Shen","year":"2013","journal-title":"Scand. J. Rheumatol."},{"issue":"7","key":"10.1016\/j.cyto.2020.154994_b0110","doi-asserted-by":"crossref","first-page":"3058","DOI":"10.1167\/iovs.07-1390","article-title":"Upregulated IL-23 and IL-17 in Beh\u00e7et\u2019 patients with active uveitis","volume":"49","author":"Chi","year":"2008","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"issue":"8","key":"10.1016\/j.cyto.2020.154994_b0115","doi-asserted-by":"crossref","first-page":"2136","DOI":"10.1038\/jid.2010.114","article-title":"IL-17A has an important role in the acute attacks of Beh\u00e7et\u2019s disease","volume":"130","author":"Ekinci","year":"2010","journal-title":"J. Invest. Dermatol."},{"issue":"4","key":"10.1016\/j.cyto.2020.154994_b0120","doi-asserted-by":"crossref","first-page":"Cr227-34","DOI":"10.12659\/MSM.881720","article-title":"Expression of Th-17 and RORgammat mRNA in Beh\u00e7et\u2019s Disease","volume":"17","author":"Hamzaoui","year":"2011","journal-title":"Med. Sci. Monit.: Int. Med. J. Exp. Clin. Res."},{"issue":"1\u20132","key":"10.1016\/j.cyto.2020.154994_b0125","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.jneuroim.2011.01.012","article-title":"RORC and Foxp3 axis in cerebrospinal fluid of patients with neuro-Beh\u00e7et\u2019s disease","volume":"233","author":"Hamzaoui","year":"2011","journal-title":"J. Neuroimmunol."},{"issue":"4","key":"10.1016\/j.cyto.2020.154994_b0130","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1080\/030097402320318387","article-title":"Cytokine profile in Beh\u00e7et\u2019s disease patients. Relationship with disease activity","volume":"31","author":"Hamzaoui","year":"2002","journal-title":"Scand. J. Rheumatol."},{"issue":"7","key":"10.1016\/j.cyto.2020.154994_b0135","doi-asserted-by":"crossref","first-page":"1857","DOI":"10.1007\/s10067-015-2966-2","article-title":"Possible association of proinflammatory cytokines including IL1beta and TNFalpha with enhanced Th17 cell differentiation in patients with Beh\u00e7et\u2019s disease","volume":"35","author":"Shimizu","year":"2016","journal-title":"Clin. Rheumatol."},{"key":"10.1016\/j.cyto.2020.154994_b0140","doi-asserted-by":"crossref","unstructured":"I.T.f.t.R.o.t.I.C.f.B.s.D. (ITR-ICBD), The International Criteria for Beh\u00e7et\u2019s Disease (ICBD): a collaborative study of 27 countries on the sensitivity and specificity of the new criteria, J. Eur. Acad. Dermatol. Venereol.: JEADV 28(3) (2014) 338\u201347. doi:10.1111\/jdv.12107.","DOI":"10.1111\/jdv.12107"},{"key":"10.1016\/j.cyto.2020.154994_b0145","first-page":"134","article-title":"Iran Beh\u00e7et\u2019s disease dynamic activity measure. Abstracts of the XIIth European congress of rheumatology","volume":"32","author":"Davatchi","year":"1991","journal-title":"Hungarian Rheumatol."},{"issue":"1","key":"10.1016\/j.cyto.2020.154994_b0150","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1093\/rheumatology\/keg453","article-title":"The Beh\u00e7et\u2019s disease activity index","volume":"43","author":"Lawton","year":"2004","journal-title":"Rheumatology (Oxford, England)"},{"issue":"5","key":"10.1016\/j.cyto.2020.154994_b0155","doi-asserted-by":"crossref","first-page":"536","DOI":"10.3109\/s10165-009-0191-z","article-title":"Comparison of existing disease activity indices in the follow-up of patients with Beh\u00e7et\u2019s disease","volume":"19","author":"Shahram","year":"2009","journal-title":"Mod. Rheumatol."},{"issue":"3 Suppl 77","key":"10.1016\/j.cyto.2020.154994_b0160","first-page":"32","article-title":"Up-regulation of Th17 and related cytokines in Beh\u00e7et\u2019s disease corresponding to disease activity","volume":"31","author":"Na","year":"2013","journal-title":"Clin. Exp. Rheumatol."},{"issue":"3","key":"10.1016\/j.cyto.2020.154994_b0165","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1111\/j.1365-2567.2009.03240.x","article-title":"Interleukin-17 and its target genes: mechanisms of interleukin-17 function in disease","volume":"129","author":"Onishi","year":"2010","journal-title":"Immunology"},{"issue":"4 Suppl 60","key":"10.1016\/j.cyto.2020.154994_b0170","first-page":"S16","article-title":"Imbalance of Th17 to Th1 cells in Beh\u00e7et\u2019s disease","volume":"28","author":"Kim","year":"2010","journal-title":"Clin. Exp. Rheumatol."},{"issue":"2","key":"10.1016\/j.cyto.2020.154994_b0175","first-page":"65","article-title":"CD4(+) T cells from Beh\u00e7et\u2019 patients produce high levels of IL-17","volume":"26","author":"Chi","year":"2011","journal-title":"Eye Sci."},{"issue":"5","key":"10.1016\/j.cyto.2020.154994_b0180","doi-asserted-by":"crossref","first-page":"358","DOI":"10.5114\/pdia.2015.54745","article-title":"Serum IL-17A in Beh\u00e7et\u2019s disease","volume":"32","author":"Emiroglu","year":"2015","journal-title":"Postepy dermatologii i alergologii"},{"issue":"4 Suppl 60","key":"10.1016\/j.cyto.2020.154994_b0185","first-page":"S27","article-title":"A Th1 but not a Th17 response is present in the gastrointestinal involvement of Beh\u00e7et\u2019s disease","volume":"28","author":"Ferrante","year":"2010","journal-title":"Clin. Exp. Rheumatol."},{"key":"10.1016\/j.cyto.2020.154994_b0190","doi-asserted-by":"crossref","DOI":"10.1155\/2012\/209316","article-title":"Histopathological evaluation of Beh\u00e7et\u2019s disease and identification of new skin lesions","volume":"2012","author":"Gunduz","year":"2012","journal-title":"Pathol. Res. Int."},{"key":"10.1016\/j.cyto.2020.154994_b0195","first-page":"4309485","article-title":"Cytokines as biomarkers and their respective clinical cutoff levels","volume":"2017","author":"Monastero","year":"2017","journal-title":"Int. J. Inflam."}],"container-title":["Cytokine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043466620300107?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043466620300107?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T20:58:33Z","timestamp":1760907513000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1043466620300107"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3]]},"references-count":39,"alternative-id":["S1043466620300107"],"URL":"https:\/\/doi.org\/10.1016\/j.cyto.2020.154994","relation":{},"ISSN":["1043-4666"],"issn-type":[{"value":"1043-4666","type":"print"}],"subject":[],"published":{"date-parts":[[2020,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Interleukin-17 mRNA expression and serum levels in Beh\u00e7et\u2019s disease","name":"articletitle","label":"Article Title"},{"value":"Cytokine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cyto.2020.154994","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"154994"}}